Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

35.99
Delayed Data
As of Sep 03
 -0.03 / -0.08%
Today’s Change
33.75
Today|||52-Week Range
45.43
-3.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line66.9M38.8M35.1M16.9M
 
 
 
 
 
Depreciation50.0M65.5M81.7M86.1M
 
 
 
 
 
Total Other Cash Flow8.1M17.4M21.0M19.7M
 
 
 
 
 
Funds From Operations130.8M122.3M137.6M126.8M
 
 
 
 
 
Funds From/For Other Operating Expenses15.5M37.2M-1.9M-331.0K
 
 
 
 
 
Net Cash Flow - Operating Activities115.3M85.1M139.5M127.2M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-1.0M-23.1M0.00
 
 
 
Capital Expenditures-53.2M-62.2M-73.6M-122.2M
 
 
 
 
 
Fixed Asset Disposal1.0M2.0M488.0K452.0K
 
 
 
 
 
Net Assets From Acquisitions 0.00-535.2M-9.5M0.00
 
 
 
Net Cash Flow Investing-52.2M-596.4M-105.8M-121.8M
 
 
 
 
 
 
FinancingShort Term Borrowings-288.0K7.4M-5.5M843.0K
 
 
 
 
 
Long Term Borrowings0.00469.5M0.00-1.0M
 
 
 
Long Term Debt Reduction-815.0K-886.0K-38.0M-9.6M
 
 
 
 
 
Net Proceeds Stock Sale19.2M31.7M20.5M14.1M
 
 
 
 
 
Common Preferred Redeemed-50.0M-50.0M0.00-39.0M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.4M4.1M2.4M1.6M
 
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-30.5M461.9M-20.7M-33.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-498.0K-273.0K355.0K-4.1M
 
 
 
 
 
 
Net Change In Cash32.7M-49.5M13.0M-27.8M